Related Experiment Video
Updated: May 29, 2025

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
Global cervical cancer elimination: quantifying the status, progress, and gaps.
Liangru Zhou1, Yi Li2, Hongyun Wang1
1School of Management, Beijing University of Chinese Medicine, 11 Of North Three-Ring East Road, Chao Yang District, Beijing, 100029, NO, China.
Global cervical cancer (CC) elimination efforts show significant progress in vaccination and screening, yet major inequalities persist, particularly in low- and middle-income countries (LMICs). Addressing these disparities is crucial for achieving WHO
Area of Science:
- Oncology
- Public Health
- Epidemiology
Background:
- The World Health Organization (WHO) has initiated a global commitment for cervical cancer (CC) elimination, involving 194 countries.
- Progress in CC elimination is assessed through the implementation of primary (human papillomavirus [HPV] vaccination), secondary (CC screening), and tertiary (CC treatment) prevention strategies.
- Interim targets for the Global Strategy for Cervical Cancer Elimination are evaluated.
Purpose of the Study:
- To quantitatively assess global progress towards cervical cancer elimination targets.
- To analyze the implementation of HPV vaccination, CC screening, and CC treatment across 194 countries.
- To identify disparities in CC prevention and treatment based on national income and geographic location.
Main Methods:
- Data were collected from the International Agency for Research on Cancer, WHO, UNICEF, and national capacity surveys.
- A retrospective analysis examined data from 194 countries and regions, stratified by income (high-income countries [HICs] vs. low- and middle-income countries [LMICs]) and geography.
- Quantitative assessment of global progress in primary, secondary, and tertiary CC prevention.
Main Results:
- By 2020, only four countries met the target of 90% HPV vaccination coverage for girls by age 15.
- As of 2021, 115 countries had integrated HPV vaccination into national programs, and 133 countries had implemented CC screening programs.
- While 126 countries have national CC management guidelines, tertiary prevention indicators like opioid consumption suggest underutilization of treatment services, especially in LMICs.
Conclusions:
- Significant inequalities in CC vaccination and screening access persist globally, with limited access in most LMICs.
- Targeting vulnerable populations and economically underdeveloped regions is essential to reduce inequity and accelerate CC elimination.
- Tertiary prevention appears more established in LMICs, but indirect indicators suggest underutilization of cancer treatment services.
Related Concept Videos
Cancer Survival Analysis
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

